Reckling W Carlton 4
4 · SI-BONE, Inc. · Filed Dec 17, 2019
Insider Transaction Report
Form 4
SI-BONE, Inc.SIBN
Reckling W Carlton
CMO and VP, Medical Affairs
Transactions
- Exercise/Conversion
Common Stock
2019-12-13$3.96/sh+5,000$19,800→ 16,740 total - Exercise/Conversion
Common Stock
2019-12-13$3.96/sh+5,000$19,800→ 21,740 total - Sale
Common Stock
2019-12-13$20.06/sh−5,000$100,282→ 16,740 total - Exercise/Conversion
Common Stock
2019-12-16$3.96/sh+5,000$19,800→ 16,740 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-12-16−5,000→ 25,554 totalExercise: $3.96Exp: 2023-03-18→ Common Stock (5,000 underlying) - Sale
Common Stock
2019-12-16$20.00/sh−5,000$100,000→ 11,740 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-12-13−5,000→ 30,554 totalExercise: $3.96Exp: 2023-03-18→ Common Stock (5,000 underlying) - Sale
Common Stock
2019-12-13$20.00/sh−5,000$100,000→ 11,740 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-12-13−5,000→ 35,554 totalExercise: $3.96Exp: 2023-03-18→ Common Stock (5,000 underlying)
Footnotes (4)
- [F1]The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
- [F2]The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.26, inclusive.
- [F3]Includes 8,287 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.
- [F4]The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.